A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.


Autoria(s): Grimaldi L.; Barkhof F.; Beelke M.; Burton J.; Holmoy T.; Hupperts R.; Killestein J.; Rieckmann P.; Schluep M.; Smolders J.; SOLAR Study Group
Data(s)

2012

Identificador

http://serval.unil.ch/?id=serval:BIB_7EB06D65A6C9

isbn:1526-632X (Electronic)

pmid:22411961

doi:10.1212/01.wnl.0000413180.13413.ce

Idioma(s)

en

Fonte

Neurology, vol. 78, no. 11, pp. 841

Palavras-Chave #25-Hydroxyvitamin D 2/therapeutic use; Female; Humans; Male; Multiple Sclerosis, Relapsing-Remitting/drug therapy; Vitamins/therapeutic use
Tipo

info:eu-repo/semantics/article

article